首页 › 基金 › Saturn V Capital Management LP › RARE
Saturn V Capital Management LP 对 RARE 的持仓历史
ULTRAGENYX PHARMACEUTICAL IN · 医疗保健
Saturn V Capital Management LP 在 Q3 2026 的 13F 申报中披露持有 RARE(ULTRAGENYX PHARMACEUTICAL IN)758,771 股,市值约 US$11.4M,约占其申报组合的 1.67%,在其申报持仓中市值排名第 18 位。 Saturn V Capital Management LP 于 Q3 2026 首次申报该持仓。
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
Saturn V Capital Management LP 对 RARE 的持仓演变
Saturn V Capital Management LP 于 Q3 2026 首次披露 RARE 持仓:758,771 股(约 US$11.4M)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2026 | 758.77K | $11.40M | 新进 |
关于 RARE 与 13F 数据
RARE(ULTRAGENYX PHARMACEUTICAL IN)属于医疗保健行业。我们追踪的基金中还有 21 只申报持有 RARE,申报仓位最大的包括:RTW INVESTMENTS, LP (US$128.2M), FRONTIER CAPITAL MANAGEMENT CO LLC (US$95.1M), Bellevue Group AG (US$66.2M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 RARE 的基金
- RTW INVESTMENTS, LP 8.53M 股 · $128.20M · Q3 2026
- FRONTIER CAPITAL MANAGEMENT CO LLC 2.85M 股 · $95.09M · Q2 2026
- Bellevue Group AG 1.98M 股 · $66.20M · Q2 2026
- MPM BioImpact LLC 1.42M 股 · $47.35M · Q2 2026
- Nantahala Capital Management, LLC 2.34M 股 · $35.16M · Q3 2026
更多关于 Saturn V Capital Management LP
常见问题
How long has Saturn V Capital Management LP held RARE?
Saturn V Capital Management LP has disclosed RARE holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Saturn V Capital Management LP's current position in RARE?
As of Q3 2026, Saturn V Capital Management LP holds 758.77K shares of RARE (ULTRAGENYX PHARMACEUTICAL IN), valued at $11.40M, representing 1.67% of its reported portfolio and ranking #18.
Has Saturn V Capital Management LP been buying or selling RARE?
In the latest 13F filing (Q3 2026), Saturn V Capital Management LP newly opened its position in RARE.
Which other funds hold RARE?
Other major institutional holders of RARE include RTW INVESTMENTS, LP, FRONTIER CAPITAL MANAGEMENT CO LLC, Bellevue Group AG, among 21 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.